These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25304234)

  • 21. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
    Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E
    Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
    Lo HW; Xia W; Wei Y; Ali-Seyed M; Huang SF; Hung MC
    Cancer Res; 2005 Jan; 65(1):338-48. PubMed ID: 15665312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR in melanoma: clinical significance and potential therapeutic target.
    Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
    J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma.
    Gammon B; Ali L; Guitart J; Gerami P
    Am J Dermatopathol; 2012 Jul; 34(5):487-90. PubMed ID: 22456513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K; Skomra D; Korobowicz E; Szymański M; Polz-Dacewicz M; Gołabek W
    Acta Otolaryngol; 2007 Jul; 127(7):760-9. PubMed ID: 17573573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
    Tobin NP; Lundgren KL; Conway C; Anagnostaki L; Costello S; Landberg G
    Hum Pathol; 2012 Nov; 43(11):2053-61. PubMed ID: 22647349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
    Chung GG; Zerkowski MP; Ocal IT; Dolled-Filhart M; Kang JY; Psyrri A; Camp RL; Rimm DL
    Cancer; 2004 May; 100(10):2084-92. PubMed ID: 15139049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma.
    Cassarino DS; Cabral ES; Kartha RV; Swetter SM
    Arch Dermatol; 2008 Jan; 144(1):49-56. PubMed ID: 18209168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
    Kaufmann C; Kempf W; Mangana J; Cheng P; Emberger M; Lang R; Kaiser AK; Lattmann E; Levesque M; Dummer R; Koelblinger P
    Histopathology; 2020 Sep; 77(3):460-470. PubMed ID: 32374893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
    Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
    J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
    Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
    Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of nuclear morphometry of primary melanoma of the skin with clinicopathological parameters and expression of tumor suppressor proteins (p53 and p16(INK4a)) and bcl-2 oncoprotein.
    Mijovic Z; Kostov M; Mihailovic D; Zivkovic N; Stojanovic M; Zdravkovic M
    J BUON; 2013; 18(2):471-6. PubMed ID: 23818364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    APMIS; 2014 Dec; 122(12):1230-9. PubMed ID: 25053516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.